DG Digest: PHMSA Harmonization, DOT Updates Drug-Test Program, and the EPA Modernizes Risk Management Plan

The week kicks off with the new Trump administration in place in Washington placing a “moratorium” on new rulemaking on the federal level.  Rulemakings already in the pipeline will potentially be delayed as well.  At press time the exact impact of the action is still somewhat cloudy.  Be sure to see next week’s blog for